BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 141 filers reported holding BIOSCRIP INC in Q2 2013. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $475,000 | -68.7% | 182,875 | -15.7% | 0.18% | -65.4% |
| Q4 2014 | $1,516,000 | -9.1% | 216,865 | -10.1% | 0.51% | -10.0% |
| Q3 2014 | $1,667,000 | -53.5% | 241,315 | -43.9% | 0.57% | -13.3% |
| Q2 2014 | $3,588,000 | +18.5% | 430,230 | -0.8% | 0.66% | +20.0% |
| Q1 2014 | $3,028,000 | +4.3% | 433,830 | +10.6% | 0.55% | +1.9% |
| Q4 2013 | $2,902,000 | -20.5% | 392,080 | +77.2% | 0.54% | +19.1% |
| Q2 2013 | $3,651,000 | – | 221,250 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |